Kanabo Group PLC Board Changes (5110F)
22 March 2022 - 06:01PM
UK Regulatory
TIDMKNB
RNS Number : 5110F
Kanabo Group PLC
22 March 2022
Kanabo Group Plc
("Kanabo" or the "Company")
Board Changes
Kanabo Group Plc (LSE:KNB), the pan-European medical cannabis
Company focussing on the development and distribution of
cannabis-derived products for medical patients and wellness CBD
consumers, announces the appointment of Gil Efron to the Company's
Board as a non-executive director, with effect from March 21(st,)
2022.
Kanabo's Audit Committee is currently chaired by Uzi Danino, who
will retire as a Non-Executive Director to focus on his other
business interests. Gil will take over as chair of the Audit
Committee following Uzi's retirement.
Gil is serving as President and Chief Financial Officer of
NASDAQ and TASE dual-listed Purple Biotech Ltd., a clinical-stage
company (PPBT) since June 2021, having previously held the position
of Deputy Chief Executive Officer and Chief Financial Officer from
October 2018. Prior to his current tenure at Purple Biotech, Gil
served as Deputy CEO and CFO of Kamada Ltd., a NASDAQ and TASE
dual-listed plasma-derived protein therapeutics company between
2011-2017.
Commenting on the appointment Avihu Tamir, founder and CEO of
Kanabo, said: "We are delighted to welcome Gil to the board. His
wealth of experience in the capital market will be an excellent
addition to Kanabo's Board, as well as his vast business and
financial management experience. The Board and I would like to
thank Uzi for his tireless dedication in bringing Kanabo to the
listed market in the UK. We have benefited greatly from his
experience and counsel over the past 3.5 years and wish him well in
all his future endeavours."
There are no details to be disclosed under paragraphs 9.6.13 (2)
to (6) of the Listing Rules.
The information communicated in this announcement is inside
information for the purposes of Article 7 of Regulation
596/2014.]
For further information, please visit
http://www.kanabogroup.com/ or contact the following:
Kanabo Group Plc Via Vox Markets
Avihu Tamir, CEO
Peterhouse Capital Ltd (Financial Tel: +44 (0)20 7469 0930
Adviser)
Eran Zucker / Lauren Riley
Peterhouse Capital Ltd (Corporate Tel: +44 (0)20 7469 0930
Broker)
Lucy Williams / Charles Goodfellow
Vox Markets (Investor Relations) KanaboGroup@voxmarkets.co.uk
Kat Perez kperez@voxmarkets.co.uk
About Kanabo Group Plc
Kanabo Group Plc is creating a new standard in the medical
cannabis industry to improve the well-being of millions of people
around the world by providing a better alternative to the smoking
of medicinal cannabis flowers. Kanabo, which was the first
medicinal cannabis company to IPO on London Stock Exchange, has a
focus on the distribution of cannabis-derived products for medical
patients and non-THC products for CBD consumers. It has conducted
extensive Research & Development to produce high-quality
cannabis extract formulas, innovative medical-grade vaporizers, and
various non-smoking consumption solutions. Kanabo sells a range of
medical cannabis products and wellness CBD products in the Primary
Markets, including its VapePod, which delivers a metered dose with
every inhalation.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAEAXDFAFXAEFA
(END) Dow Jones Newswires
March 22, 2022 03:01 ET (07:01 GMT)
Kanabo (LSE:KNB)
Historical Stock Chart
From Feb 2024 to Mar 2024
Kanabo (LSE:KNB)
Historical Stock Chart
From Mar 2023 to Mar 2024